chr17-50346170-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_022167.4(XYLT2):c.30G>T(p.Leu10Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00807 in 1,286,504 control chromosomes in the GnomAD database, including 769 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.043 ( 480 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 289 hom. )
Consequence
XYLT2
NM_022167.4 synonymous
NM_022167.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.45
Genes affected
XYLT2 (HGNC:15517): (xylosyltransferase 2) The protein encoded by this gene is an isoform of xylosyltransferase, which belongs to a family of glycosyltransferases. This enzyme transfers xylose from UDP-xylose to specific serine residues of the core protein and initiates the biosynthesis of glycosaminoglycan chains in proteoglycans including chondroitin sulfate, heparan sulfate, heparin and dermatan sulfate. The enzyme activity, which is increased in scleroderma patients, is a diagnostic marker for the determination of sclerotic activity in systemic sclerosis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 17-50346170-G-T is Benign according to our data. Variant chr17-50346170-G-T is described in ClinVar as [Benign]. Clinvar id is 1277109.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.45 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.145 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XYLT2 | NM_022167.4 | c.30G>T | p.Leu10Leu | synonymous_variant | Exon 1 of 11 | ENST00000017003.7 | NP_071450.2 | |
XYLT2 | NR_110010.2 | n.45G>T | non_coding_transcript_exon_variant | Exon 1 of 10 | ||||
XYLT2 | XM_005257572.5 | c.-726G>T | upstream_gene_variant | XP_005257629.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XYLT2 | ENST00000017003.7 | c.30G>T | p.Leu10Leu | synonymous_variant | Exon 1 of 11 | 1 | NM_022167.4 | ENSP00000017003.2 | ||
XYLT2 | ENST00000376550.7 | n.30G>T | non_coding_transcript_exon_variant | Exon 1 of 10 | 1 | ENSP00000365733.3 | ||||
XYLT2 | ENST00000507602.5 | c.30G>T | p.Leu10Leu | synonymous_variant | Exon 1 of 10 | 2 | ENSP00000426501.1 | |||
XYLT2 | ENST00000509778.1 | c.30G>T | p.Leu10Leu | synonymous_variant | Exon 1 of 2 | 3 | ENSP00000425511.1 |
Frequencies
GnomAD3 genomes AF: 0.0433 AC: 6410AN: 147942Hom.: 482 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6410
AN:
147942
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00521 AC: 437AN: 83880 AF XY: 0.00326 show subpopulations
GnomAD2 exomes
AF:
AC:
437
AN:
83880
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00348 AC: 3965AN: 1138454Hom.: 289 Cov.: 30 AF XY: 0.00301 AC XY: 1689AN XY: 560850 show subpopulations
GnomAD4 exome
AF:
AC:
3965
AN:
1138454
Hom.:
Cov.:
30
AF XY:
AC XY:
1689
AN XY:
560850
Gnomad4 AFR exome
AF:
AC:
3432
AN:
21926
Gnomad4 AMR exome
AF:
AC:
120
AN:
20250
Gnomad4 ASJ exome
AF:
AC:
2
AN:
16528
Gnomad4 EAS exome
AF:
AC:
0
AN:
17230
Gnomad4 SAS exome
AF:
AC:
14
AN:
63136
Gnomad4 FIN exome
AF:
AC:
0
AN:
29802
Gnomad4 NFE exome
AF:
AC:
74
AN:
925046
Gnomad4 Remaining exome
AF:
AC:
309
AN:
41458
Heterozygous variant carriers
0
194
389
583
778
972
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0433 AC: 6412AN: 148050Hom.: 480 Cov.: 32 AF XY: 0.0420 AC XY: 3033AN XY: 72166 show subpopulations
GnomAD4 genome
AF:
AC:
6412
AN:
148050
Hom.:
Cov.:
32
AF XY:
AC XY:
3033
AN XY:
72166
Gnomad4 AFR
AF:
AC:
0.148139
AN:
0.148139
Gnomad4 AMR
AF:
AC:
0.0161095
AN:
0.0161095
Gnomad4 ASJ
AF:
AC:
0.000879765
AN:
0.000879765
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000621375
AN:
0.000621375
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000331465
AN:
0.000331465
Gnomad4 OTH
AF:
AC:
0.0213385
AN:
0.0213385
Heterozygous variant carriers
0
281
562
843
1124
1405
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Osteogenesis imperfecta Benign:1
Aug 13, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Spondylo-ocular syndrome Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at